Repare Therapeutics (RPTX) Revenue & Revenue Breakdown
Repare Therapeutics Revenue Highlights
Main Geography (Y)
UNITED STATES
Repare Therapeutics Revenue by Period
Repare Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | -100.00% |
| 2022-12-31 | $131.83M | 1634.61% |
| 2021-12-31 | $7.60M | 5529.63% |
| 2020-12-31 | $135.00K | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2018-12-31 | - | 100.00% |
| 2017-12-31 | - | - |
Repare Therapeutics generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Repare Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | - | -100.00% |
| 2024-03-31 | $52.40M | 301.66% |
| 2023-12-31 | $13.05M | 504.31% |
| 2023-09-30 | $2.16M | -92.86% |
| 2023-06-30 | $30.25M | 432.74% |
| 2023-03-31 | $5.68M | -68.80% |
| 2022-12-31 | $18.20M | -83.83% |
| 2022-09-30 | $112.55M | 16475.11% |
| 2022-06-30 | $679.00K | 66.42% |
| 2022-03-31 | $408.00K | -94.07% |
| 2021-12-31 | $6.88M | 2373.74% |
| 2021-09-30 | $278.00K | -0.36% |
| 2021-06-30 | $279.00K | 68.07% |
| 2021-03-31 | $166.00K | 22.96% |
| 2020-12-31 | $135.00K | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | 100.00% |
| 2019-12-31 | - | 100.00% |
| 2019-09-30 | - | 100.00% |
| 2019-06-30 | - | 100.00% |
| 2019-03-31 | - | - |
Repare Therapeutics generated - in revenue during Q2 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Repare Therapeutics Revenue Breakdown
Repare Therapeutics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| UNITED STATES | $26.10M | $15.20M | - |
| SWITZERLAND | $14.50M | $116.60M | - |
| JAPAN | $10.50M | - | - |
| U S | - | - | $7.60M |
Repare Therapeutics's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (51.08%), SWITZERLAND (28.38%), and JAPAN (20.55%).
RPTX Revenue FAQ
What is Repare Therapeutics’s yearly revenue?
Repare Therapeutics's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $131.83M, representing an increase of 1634.61% compared to 2021. RPTX's yearly revenue for 2021 was $7.6M, representing an increase of 5529.63% compared to 2020.
What is Repare Therapeutics’s quarterly revenue?
Repare Therapeutics's quarterly revenue for Q2 2024 was $0, a -100.00% decrease from the previous quarter (Q1 2024), and a -100.00% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $52.4M, a 301.66% increase from the previous quarter (Q4 2023), and a 822.93% increase year-over-year (Q1 2023). RPTX's quarterly revenue for Q4 2023 was $13.05M, a 504.31% increase from the previous quarter (Q3 2023), and a -28.31% decrease year-over-year (Q4 2022).
What is Repare Therapeutics’s revenue growth rate?
Repare Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was 0%.